Publications

It is that time of year again to celebrate the scientific discoveries and innovations as reviewed by different organizations and publications. Among this year's Popular Science top health innovations of 2017 is Philips' IntelliSite Pathology...

I don’t recall where I read it but I do recall when. In a page of a book written by a physician, he lamented there are three things that can change a person’s life forever (perhaps not in this order but as I recall it): Going to medical...

It will come as no surprise to anyone in the digital pathology space that Philips has been transforming the digital pathology market from several directions. Of course, the company completed a non-inferiority study which has been published in...

Although a surgeon’s goal is to remove cancer in its entirety during excision surgery, achieving negative margins (absence of cancer cells at the outer edge of the excised tumor specimen) can be challenging. To facilitate intraoperative...

Last month the FDA approved pembrolizumab (KEYTRUDA) for adult and pediatric patients with with metastatic or unresectable, microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) solid tumors that have...

With the ink dry about a month on the recent FDA approval of Philips Intellisite Pathology Solution (PIPS) for primary diagnosis, I came across this headline and others like it last week. Well known, respected pathologists and pathology...